Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02596893
Other study ID # GED-0301-CD-002
Secondary ID
Status Terminated
Phase Phase 3
First received
Last updated
Start date December 8, 2015
Est. completion date January 5, 2018

Study information

Verified date August 2019
Source Celgene
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of study is to test the effects of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease. The study will test GED-0301 compared to placebo for 52 weeks. The study treatment is blinded which means that patients and the study doctor will not know which treatment has been assigned. Patients in this study will be allowed treatment with stable doses of oral aminosalicylates, oral corticosteroids, immunosupressants and antibiotics for the treatment of Crohn's disease.

After 12 weeks in the study until the end of the study, patients who do not have an improvement in their Crohns disease symptoms will have the option to enter a long term active treatment study. Participants who discontinued the study anytime or completed the study at Week 52 were then observed for an additional 4 weeks.


Recruitment information / eligibility

Status Terminated
Enrollment 701
Est. completion date January 5, 2018
Est. primary completion date January 5, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Subjects must satisfy the following criteria to be enrolled in the study:

- Male or female = 18 years

- Active Crohn's disease (CD) disease as determined by the Crohn's Disease Activity Index (CDAI) score and the Simple Endoscopic Score for Crohn's Disease (SES-CD)

- Must meet a determined average minimum number of daily stools or rating of abdominal pain over a 7 day period

- Subject must have failed or experienced intolerance to at least one of the following: budesonide; systemic corticosteroids; immunosuppressants (eg, azathiopurine, 6-mercaptopurine, or methotrexate); or biologics for the treatment of CD.

Exclusion Criteria:

The presence of any of the following will exclude a subject from enrollment:

- Diagnosis of ulcerative colitis (UC), indeterminate colitis, ischemic colitis, microscopic colitis, radiation colitis or diverticular disease-associated colitis

- Local manifestations of Crohn's Disease (CD) such as symptomatic/severe strictures, abscesses, short bowel syndrome; or other disease complications for which surgery might be indicated or could confound the evaluation of efficacy

- Intestinal resection within 6 months or any intra-abdominal surgery within 3 months prior to the Screening Visit

- Ileostomy or a colostomy

- Subject has a history of any clinically significant medical condition that, in the investigator's opinion, would prevent the subject from participating in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
GED-0301

Placebo


Locations

Country Name City State
Australia Royal Adelaide Hospital Adelaide South Australia
Australia Ballarat Base Hospital Ballarat
Australia Bankstown-Lidcombe Hospital Bankstown Australian Capital Territory
Australia Flinders Medical Centre Bedford Park South Australia
Australia Monash Medical Centre Clayton Bentleigh East
Australia Box Hill Hospital Box Hill Victoria
Australia Royal Prince Alfred Hospital Camperdown New South Wales
Australia Concord Repatriation General Hospital Concord New South Wales
Australia St Vincents Hospital Melbourne Fitzroy
Australia Centre For Digestive Diseases Five Dock New South Wales
Australia Austin Hospital Heidelberg
Australia Royal Brisbane and Women's Hospital Herston
Australia Nepean Hospital Kingswood, NSW
Australia Liverpool Hospital Liverpool New South Wales
Australia The Alfred Hospital Melbourne Victoria
Australia Fiona Stanley Hospital Murdoch Western Australia
Australia Mater Adult Hospital South Brisbane Queensland
Australia Princess Alexandra Hospital Woolloongabba Queensland
Austria LKH Universitaetsklinikum Graz Graz
Austria Medizinische Universitat Innsbruck Innsbruck
Austria Klinikum Klagenfurt am Wörtersee Klagenfurt
Austria KH der Barmherzigen Bruder Linz Linz
Austria a.o.Krankenhaus d.Barmherz.Schwestern Ried Ried I Innkreis
Austria LKH - Universitätsklinikum der PMU Salzburg Salzburg
Austria Ordination Dr. Thomas Haas Darmpraxis Salzburg Salzburg
Austria KH der Barmherzigen Brüder St.Veit an der Glan St Veit An Der Glan
Austria AKH Medizinische Universitat Wien Wein
Austria Krankenanstalt Rudolfstiftung Wien Wein
Belgium Universitair Ziekenhuis Brussel Brussels
Belgium Cliniques Universitaires St Luc Bruxelles
Belgium Universitair Ziekenhuis Gent Gent
Belgium UZ Leuven Leuven
Belgium CHU Sart Tilman Liege
Belgium Centre Hospitalier de Mouscron Mouscron
Bulgaria MHAT Sv Nikolay Chudotvorets EOOD Lom
Bulgaria MHAT Kaspela EOOD Plovdiv
Bulgaria MHAT Ruse AD Ruse
Bulgaria City Clinic UMHAC EOOD Sofia
Bulgaria Fourth MHAT Sofia EAD Sofia
Bulgaria MHAT Doverie AD Sofia
Bulgaria Second MHAT Sofia AD Sofia
Bulgaria UMHAT Sv Ivan Rilski EAD Sofia
Bulgaria UMHAT Tsaritsa Yoanna - ISUL EAD Sofia
Canada Barrie GI Associates Barrie Ontario
Canada Brandon Medical Arts Clinic Brandon Manitoba
Canada University of Calgary Calgary Alberta
Canada GI Research Institute Edmonton Alberta
Canada South Edmonton Gastroenterology Edmonton Alberta
Canada University of Alberta Edmonton Alberta
Canada Centre de sante et de services sociaux Champlain Charles Le Moyne Greenfield Park Quebec
Canada McMaster University Health Sciences Center Hamilton Ontario
Canada LHSC Victoria Hospital London Ontario
Canada London Health Science Center U. Hospital London Ontario
Canada CHUM Hôpital Saint-Luc Montreal Quebec
Canada Hopital Maisonneuve Rosemont dba CIUSSS de lEst de lIle de Montreal Montreal Quebec
Canada McGill University Health Centre Glen Site Royal Victoria Hospital Montreal Quebec
Canada Recherche GCP Research Montreal Quebec
Canada Montfort Hospital Ottawa Ontario
Canada Recherche Clinique Sigma Inc Quebec
Canada Royal University Hospital Saskatoon Saskatchewan
Canada CHUS Hopital Fleurimont Sherbrooke Quebec
Canada Recherche Medicale St Jerome Inc St Jerome Quebec
Canada Humber River Hospital Toronto Ontario
Canada Mount Sinai Hospital Toronto Ontario
Canada Toronto Liver Centre Toronto Ontario
Canada GI Research Institute Vancouver British Columbia
Canada Vancouver General Hospital Vancouver British Columbia
Canada Toronto Digestive Disease Associates Inc Vaughan Ontario
Canada PerCuro Clinical Research Victoria British Columbia
Canada Medicine Professional Corporation Waterloo Ontario
Canada Tarabain Osman MD Windsor Ontario
Croatia Clinical Hospital Centre Osijek Osijek
Croatia Clinical Hospital Centre Rijeka Rijeka
Croatia Clinical Hospital Centre Zagreb Zagreb
Croatia Clinical Hospital Dubrava Zagreb
Croatia Clinical Hospital Merkur Zagreb
Croatia Clinical Hospital Sveti Duh Zagreb
Czechia Fakultni nemocnice u sv Anny v Brne Brno
Czechia Hepato-Gastroenterologie HK Hradec Kralove
Czechia Soukroma Gastroenterologicka ambulance a endoskopie Most
Czechia PreventaMed Olomouc
Czechia CCBR Czech as Pardubice
Czechia CCBR Prague CZ Praha 3
Czechia IBD Centrum ISCARE IVF as Praha 7
Czechia Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad La Usti nad Labem
Czechia Nemocnice Znojmo Znojmo
Denmark Aarhus Universitetshospital Aahus C
Denmark Alborg University Hospital Ålborg
Denmark Nordsjaellands Hospital Frederikssund Frederikssund
Denmark Herlev Hospital Herlev
Denmark Hvidovre Hospital Hvidovre
Denmark Koge Sygehus Koge
Denmark Regionshospitalet Silkeborg Silkeborg
Estonia West Tallinn Central Hospital Tallinn
Estonia Tartu University Hospital Tartu
Finland Tampereen yliopistollinen sairaala Tampere
Finland Turunmaan sairaala Turku
France CHU Amiens Hopital Sud Amiens Cedex
France CHU Besancon Hopital Jean Minjoz Besancon Cedex
France CHU Tours Hopital Trousseau Chambray les Tours
France CHU Clermont Ferrand Clermont-Ferrand
France Hopital Beaujon Clichy cedex
France CHU Dijon - Hopital Bocage Central Dijon
France CHU de Grenoble Hopital Nord Grenoble cedex 9
France Groupement Hospitalier Sud Hopital Bicetre Le Kremlin Bicetre cedex
France Hopital Claude Huriez CHRU Lille Lille cedex
France Hopital Nord Marseille cedex 20
France CHU Nantes Hotel Dieu Nantes Cedex 1
France CHU Nice Hopital de lArchet 2 Nice Cedex 3
France Hopital Saint Antoine Paris
France Hopital Saint Louis Paris
France Groupe Hospitalier Sud Hopital Haut Leveque USN Pessac
France Centre Hospitalier Lyon Sud Pierre-Bénite Cedex
France CHU Reims Hopital Robert Debre Reims
France CHU Rennes Hopital Pontchaillou Rennes cedex 09
France CHU de Rouen Hopital Charles Nicolle Rouen Cedex
France CHU Saint Etienne Hopital Nord Saint Etienne
France CHU Strasbourg Hopital Hautepierre Strasbourg Cedex
France CHU de Toulouse Hopital Rangueil Toulouse Cedex 09
France Hopital de Brabois Adultes Vandoeuvre les Nancy
Germany Charite Campus Virchow Klinikum Berlin
Germany Charite Universitaetsmedizin Berlin Campus Benjamin Franklin Berlin
Germany DRK Kliniken Berlin Westend Berlin
Germany Krankenhaus Waldfriede e V Berlin
Germany Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH Bochum
Germany Staedisches Klinikum Brandenburg Brandenburg an der Havel
Germany Universitaetsklinikum Carl Gustav Carus TU Dresden Dresden
Germany Zentrum fuer HIV und Hepatogastroenterologie GmbH Duesseldorf
Germany Universitaetsklinikum Erlangen Erlangen
Germany Katholische Kliniken Ruhrhalbinsel GmbH Essen
Germany Kliniken Essen-Mitte Essen
Germany Agaplesion Markus Krankenhaus Frankfurt
Germany Crohn Colitis Centrum Rhein Main Frankfurt
Germany Universitaetsklinikum FreiburgInnere Med.1, Haematologie Freiburg
Germany Universitaetsklinikum Halle Saale Halle
Germany Asklepios Klinik Hamburg Hamburg
Germany Medizinische Hochschule Hannover Hannover
Germany Praxis fuer Gastroenterologie Dr Ehehal Dr Helmstaedter Heidelberg
Germany Universitatsklinikum Heidelberg Heidelberg
Germany Universitaetsklinikum Jena Jena
Germany Universitaetsklinikum Schleswig Holstein Campus Kiel Kiel
Germany EUGASTRO GmbH Leipzig
Germany Internistische Gemeinschaftspraxis f. Verdauungs- und Stoffwechselerkrankungen Leipzig
Germany University Leipzig Leipzig
Germany Medizinisches Zentrum Klinikum Lueneburg Lueneburg
Germany Universitaetsklinikum Magdeburg A oeR Magdeburg
Germany Klinikum Mannheim GmbH Universitaetsklinikum Mannheim
Germany Gastroenterologische Praxis Minden Minden
Germany Isar Klinik GmbH Muenchen
Germany Gastro Campus Research Muenster
Germany Universitaetsklinikum Muenster Muenster
Germany Klinikum der Universitaet Muenchen München
Germany Staedtisches Klinikum Braunschweig gGmbH Standort Salzdahlumer Niedersachsen
Germany Universitaetsklinikum Regensburg Regensburg
Germany Universitaetsklinikum Ulm Ulm
Greece University General Hospital of Alexandroupolis Alexandroupolis
Greece Athens Medical Center Athens
Greece General Hospital of Athens Evangelismos Athens
Greece General Hospital of Nikaea Piraeus Ag. Panteleimon Athens
Greece General Hospital of Heraklion Benizeleio Pananeio Heraklion
Greece University General Hospital of Heraklion Heraklion
Greece University General Hospital of Ioannina Ioannina
Greece University General Hospital of Patras Rio Patras
Greece Anticancer Hospital of Thessaloniki THEAGENIO Thessaloniki
Greece General Hospital of Thessaloniki Hippokration Thessaloniki
Hungary DRC Gyogyszervizsgalo Kozpont Kft Balatonfured
Hungary Clinexpert Egeszsegugyi Szolg es Ker Kft Budapest
Hungary Endomedix Diagnosztikai Kozpont Budapest
Hungary Magyar Honvedseg Egeszsegugyi Kozpont Budapest
Hungary Pannonia Maganorvosi Centrum Budapest
Hungary Semmelweis Egyetem AOK Budapest
Hungary Semmelweis Egyetem AOK Budapest
Hungary Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak Budapest
Hungary Debreceni Egyetem Klinikai Kozpont Debrecen
Hungary Szent Pantaleon Korhaz Rendelointezet Dunaujvaros Dunaujvaros
Hungary Markhot Ferenc Oktato Korhaz es Rendelointezet Eger
Hungary Petz Aladar Megyei Oktato Korhaz Gyor
Hungary Bekes Megyei Pandy Kalman Korhaz Gyula
Hungary Somogy Megyei Kaposi Mor Oktato Korhaz Kaposvar
Hungary Mohacsi Korhaz Mohacs
Hungary SzSzB Megyei Korhazak es Egyetemi Oktatokorhaz Nyiregyhaza
Hungary Mazso-Pharma Kutatas-fejlesztesi Kft Szeged
Hungary Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz Szekesfehervar
Hungary Clinfan Szolgaltato Kft Szekszard
Israel HaEmek Medical Center Afula
Israel Soroka University Medical Center Beer Sheva
Israel Rambam Health Care Campus Haifa
Israel Wolfson Medical Center Holon
Israel Hadassah University Hospital Jerusalem
Israel Shaare Zedek Medical Center Jerusalem
Israel Rabin Medical Center Petah Tikva
Israel Chaim Sheba Medical Center Ramat Gan
Israel Kaplan Medical Center Rechovot
Israel Tel Aviv Sourasky Medical Center Department of Hematology Tel Aviv
Israel Assaf Harofeh Medical Center Zerifin
Italy Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari
Italy Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi Bologna
Italy Azienda Ospedaliera Universitaria Policlinico G Martino Messina
Italy Fondazione IRCCS CA Granda Ospedale Maggiore Policlinico Milano
Italy Seconda Universita Degli Studi Di Napoli Naples
Italy Azienda Ospedaliera Universitaria Federico II Napoli, Campania
Italy Hospital of Di Padova Padova
Italy Azienda Ospedaliera Vincenzo Cervello Palermo
Italy Fondazione IRCCS Policlinico San Matteo Pavia
Italy Azienda Ospedaliero Universitaria Pisana Pisa
Italy Complesso Integrato Columbus Roma
Italy Ospedale Sandro Pertini Roma
Italy Policlinico Universitario Agostino Gemelli Roma
Italy Universita Campus Bio-Medico di Roma Roma
Italy Azienda Ospedaliera San Camillo Forlanini Rome
Italy Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome
Italy Istituto Clinico Humanitas Rozzano (MI)
Italy Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi dAragona Salerno
Italy IRCCS Policlinico San Donato San Donato Milanese
Italy IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo FG
Korea, Republic of Dong-A University Hospital Busan
Korea, Republic of Pusan National University Hospital Busan
Korea, Republic of Yeungnam University Medical Center Daegu
Korea, Republic of Hanyang Univerisy Guri Hospital Guri-si
Korea, Republic of Seoul National University Bundang Hospital Seongnam-si
Korea, Republic of CHA Bundang Medical Center CHA University Seongnam-si,
Korea, Republic of Asan Medical Center Seoul
Korea, Republic of Ewha Womans University Mokdong Hospital Seoul
Korea, Republic of Kangbuk Samsung Hospital Seoul
Korea, Republic of Korea University Anam Hospital Seoul
Korea, Republic of Kyung Hee University Hospital Seoul
Korea, Republic of Samsung Medical Center Seoul
Korea, Republic of Severance Hospital, Yonsei University Health System Seoul
Korea, Republic of The Catholic University of Korea, St.Vicent's Hospital Suwon-si
Latvia Digestive Diseases Center Gastro Riga
Latvia Pauls Stradins Clinical University Hospital Riga
Latvia Riga East Clinical University Hospital clinic Gailezers Riga
Malaysia Hospital Sultanah Bahiyah Alor Setar Kedah
Malaysia Hospital Ampang Ampang Selangor
Malaysia Hospital Universiti Sains Malaysia Kelantan
Malaysia Hospital Raja Perempuan Zainab II Kota Bahru Kelantan
Malaysia University Malaya Medical Centre Kuala Lumpur Wilayah Persekutuan Kuala Lumpur
Netherlands Academisch Medisch Centrum Amsterdam
Netherlands VU Medisch Centrum Amsterdam
Netherlands Amphia Ziekenhuis Breda
Netherlands Universitair Medisch Centrum Groningen Groningen
Netherlands Leiden Universitair Medisch Centrum Leiden
Netherlands Medisch Centrum Haaglanden,Antoniushoeve Leidschendam
Netherlands Radboudumc Nijmegen
Netherlands Zuyderland Medisch Centrum Sittard-Geleen
Netherlands St. Elisabeth Ziekenhuis Tilburg
Netherlands University Medical Center Utrecht Utrecht
New Zealand Waikato Hospital Hamilton
Norway Sykehuset Ostfold Fredrikstad Fredrikstad
Norway Akershus universitetssykehus HF Lørenskog
Norway Oslo Universitetssykehus HF Ulleval Oslo
Norway Oslo Universitetssykehus Rikshospitalet Oslo
Norway Stavanger Unviversitetssjukehus Helse Stavanger HF Stavanger
Poland SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego Bialystok
Poland Clinsante S.C. Osrodek Badan Klinicznych Bydgoszcz
Poland Uniwersyteckie Centrum Kliniczne Gdansk
Poland Niepubliczny Zaklad Opieki Zdrowotnej POLIMEDICA Kielce
Poland Indywidualna Praktyka Lekarska Maciej Zymla Knurow
Poland Centrum Medyczne Plejady Krakow
Poland LUX MED Sp. z o.o. Krakow
Poland SPZOZ Szpital Uniwersytecki w Krakowie Krakow
Poland Centrum Medyczne AMED Lodz
Poland SPZOZ Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej - Centralny Szpital Weteranow Lodz
Poland GASTROMED Sp.zo.o. Lublin
Poland Ai Centrum Medyczne Sp. Z O.O. Sp.K. Poznan
Poland Centrum Medyczne Medyk Rzeszow
Poland Endoskopia Sp. z o.o. Sopot
Poland Nzoz Vivamed Warsaw
Poland LexMedica Osrodek Badan Klinicznych Wroclaw
Portugal Hospital de Braga Braga
Portugal Centro Hospitalar E Universitario de Coimbra EPE Coimbra
Portugal Hospital da Senhora da Oliveira Guimaraes Guimaraes
Portugal Hospital Da Luz Lisboa
Portugal Centro Hospitalar de Sao Joao, EPE Porto
Portugal Centro Hospitalar do Alto Minho - Unidade Local de Saúde do Alto Minho, EPE Viana do Castelo
Romania S.C MedLife S.A Bucuresti
Romania Tvm Med Serv Srl Cluj Napoca
Romania Spitalul Clinic Judetean de Urgente Sf. Spiridon Iasi
Romania CMI Dr. Tirnaveanu Amelita Oradea
Romania Centrul de Gastroenterologie Dr. Goldis Timisoara
Russian Federation Irkutsk State Medical Academy of Continuing Education Irkutsk
Russian Federation TSBIH Territorial Clinical Hospital Krasnoyarsk
Russian Federation Medical Center Stolitsa-Medikl Moscow
Russian Federation SBHI of NN region RCH of NN n.a. N.A.Semashko Nizhny Novgorod
Russian Federation FSBI Scientific Research Institute of Physyology and Basic Medicine under the SB of RAMS Novosibirsk
Russian Federation RSHI State Novosibirsk Regional Clinical Hospital Novosibirsk
Russian Federation SBEIHPE Novosibirsk State Medical University Novosibirsk
Russian Federation BHI of Omsk region Clinical Oncology Dispensary Omsk
Russian Federation SBEI of HPE Omsk State Medical Academy Ministry of healthcare of RF Omsk
Russian Federation SBIH of Perm territory City Clinical Hospital 2 na Fedor Khristoforovich Gral Perm
Russian Federation Evromedservis Pushkin
Russian Federation SEIHPE Rostov State Medical University of MoH of RF Rostov-on-Don
Russian Federation City Mariinskaya Hospital Saint-Petersburg
Russian Federation SPb SBIH City Hospital # 26 Saint-Petersburg
Russian Federation NonState Healthcare Institution Central Clinical Hospital, Samara station JSC Russian Railways Samara
Russian Federation Private Educational Institution of Higher Education Medical university REAVIZ Samara
Russian Federation SHI Regional Clinical Hospital Saratov
Russian Federation SBI of Healthcare of Leningrad region Clinical Interregional Hospital of Tosno Tosno
Russian Federation SBHI of Yaroslavl Region Clinical Hospital 8 Yaroslavl
Serbia Clinical Center Bezanijska Kosa Belgrade
Serbia Clinical Center of Serbia Belgrade
Serbia Clinical Center Zemun Belgrade
Serbia Clinical Center Zvezdara Belgrade
Serbia Military Medical Academy Belgrade
Serbia Clinical Center Kragujevac Kragujevac
Serbia Clinical Center Nis Nis
Slovakia Fakultna nemocnica s poliklinikou F. D. Roosevelta Banska Bystrica
Slovakia Alian s.r.o. Bardejov
Slovakia Gastroentero-Hepatologicke centrum THALION Bratislava
Slovakia Univerzitna nemocnica Bratislava Nemocnica Ruzinov Bratislava
Slovakia Nemocnica A.Lena Humenne n o Humenne
Slovakia B & B MED, s.r.o. Kosice
Slovakia KARDIO 1 s.r.o. Lucenec
Slovakia Gastroeneterologicka ambulancia MUDr. Peter Hegyi s.r.o. Malacky
Slovakia Fakultna nemocnica Nitra Nitra
Slovakia KM Management, spol. s r.o. Nitra
Slovakia GASTRO I., s.r.o. Presov
Slovakia Nemocnica s poliklinikou sv Barbory Roznava a s Roznava
Slovakia Fakultna nemocnica s poliklinikou Zilina Zilina
Spain Hospital Universitari Germans Trias i Pujol Badalona
Spain Hospital Clinic I Provincial de Barcelona Barcelona
Spain Hospital del Mar Barcelona
Spain Hospital Universitario Reina Sofia Cordoba
Spain Hospital Universitario de la Princesa Madrid
Spain Hospital Universitario Ramon y Cajal Madrid
Spain Hospital Universitario Puerta de Hierro Majadahonda Majadahonda
Spain Corporacion Sanitaria Parc Tauli Sabadell
Spain Hospital Universitario Infanta Sofia San Sebastian de los Reyes
Spain Hospital Universitario Virgen Del Rocio Sevilla
Spain Hospital Universitario Virgen Macarena Sevilla
Spain Hospital Universitario Miguel Servet Zaragoza
Sweden Danderyds Sjukhus AB Stockholm
Sweden Sodersjukhuset Stockholm
Sweden Akademiska Sjukhuset Uppsala
Switzerland Universitaetsspital Basel Basel
Switzerland Crohn-Colitis Zentrum Bern Gemeinschaftspraxis Balsiger Seibold und Partner Bern
Switzerland Inselspital - Universitaetsspital Bern Bern
Switzerland Kantonsspital St.Gallen St. Gallen
Switzerland Universitaetsspital Zuerich Zuerich
Turkey Ankara University Medical Faculty Ankara
Turkey Gazi University Medical Faculty Ankara
Turkey Hacettepe University Medical Faculty Ankara
Turkey Turkiye Yuksek Ihtisas Hospital Ankara
Turkey Firat University Medical Faculty Elazig
Turkey Gaziantep University Medical Faculty Sahinbey Educational Research Hospital Gaziantep
Turkey Acibadem Fulya Hospital Istanbul
Turkey Haydarpasa Numune Training and Research Hospital Istanbul
Turkey Istanbul Medeniyet Uni Goztepe Training&Res Hosp Istanbul
Turkey Istanbul University Cerrahpasa Medical Faculty Hospital Istanbul
Turkey Marmara University Pendik Training and Research Hospital Istanbul
Turkey Yeditepe University Medical School Hospital Istanbul
Turkey Ege University Medical Faculty Izmir
Turkey Inonu Uni. Med. Fac. Malatya
Turkey Mersin University Medical Faculty Mersin
Turkey Kocaeli Derince Training and Research Hospital Umuttepe Kocaeli
Ukraine RCI Chernivtsi Regional Clinical Hospital Dept of Surgery Bukovinian SMU Chernivtsi
Ukraine CI of PH Kharkiv CCH #2 Kharkiv
Ukraine GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine Kharkiv
Ukraine Treatment-Diagnostic Center of Private Enterprise of PMF Atsynus Kirovohrad
Ukraine Kyiv City Clinical Hospital #1 Kyiv
Ukraine SI Republican Clinical Hospital of the MOHU Dept of Gastroenterology O.O.Bogomolets NMU Kyiv
Ukraine Ukrainian-German Antiulcer Gastroenterological Center BYK-Kyiv LLC Kyiv
Ukraine Lviv Municipal City Clinical Hospital #5 Dept of Therapy D.Halytsky Lviv NMU Lviv
Ukraine Lviv Regional Clinical Hospital D Halytskyi Lviv NMU Lviv
Ukraine CI Odesa Regional Clinical Hospital Odessa
Ukraine Communal Institution City Policlinic #20 Cabinet of Gastroenterology Odessa
Ukraine M.V. Sklifosovskyi Poltava RCH Outpatient UMSA HSEIU Ukrainian Medical Stomatological Academy Poltava
Ukraine CI of SRC Sumy RCH Dept of Rheumatology Sumy SU MI Sumy
Ukraine Ternopil City Communal Emergency Medical Care Hospital Ternopil
Ukraine M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU Vinnytsia
Ukraine SRI of Invalid Rehabilitation EST Complex of Vinnytsia M.I.Pyrogov NMU MOHU Vinnytsia
Ukraine SI Branch CH of Zaporizhzhia Station-2 of SE Prydniprovska Railway Dept of Surgery Zaporizhzhia SMU Zaporizhia
Ukraine CI Zaporizhzhia Regional Clinical Hospital of ZRC Zaporozhje
United Kingdom Queen Elizabeth Hospital Birmingham
United Kingdom Bristol Royal Infirmary Bristol
United Kingdom Royal Devon and Exeter Hospital Wonford Exeter
United Kingdom Queen Elizabeth University Hospital Glasgow
United Kingdom Glasgow Royal Infirmary Glasgow, Scotland
United Kingdom Hull Royal Infirmary Hull
United Kingdom Royal London Hospital London
United Kingdom St Marys Hospital London
United Kingdom Manchester Royal Infirmary Manchester
United Kingdom University Hospital of South Manchester NHS Foundation Trust -Wythenshawe Hospital - North West Lung Manchester
United Kingdom Nottingham University Hospitals Queens Medical Centre Nottingham
United Kingdom John Radcliffe Hospital Oxford
United Kingdom Borders General Hospital Roxburghshire
United Kingdom Royal Shrewsbury Hospital Shrewsbury
United Kingdom Southampton General Hospital Southhampton
United States Ohio Clinical Research Partners LLC Akron Ohio
United States Southwest Gastroenterology Associates PC Albuquerque New Mexico
United States HCP Clinical Research LLC Anaheim California
United States University of Michigan Health System Ann Arbor Michigan
United States Texas Clinical Research Institute LLC Arlington Texas
United States Texas Digestive Disease Consultants - Dallas Arlington Texas
United States Asheville Gastroenterology Associates, PA Asheville North Carolina
United States Atlanta Gastroenterology Associates, LLC Atlanta Georgia
United States Georgia Regents University Augusta Georgia
United States University Of Colorado Aurora Colorado
United States Johns Hopkins University School of Medicine Baltimore Maryland
United States University of Maryland Medical Center Baltimore Maryland
United States Gastroenterology Associates LLC Baton Rouge Louisiana
United States Ehrhardt Clinical Research LLC Belton Missouri
United States Boston Medical Center Boston Massachusetts
United States Graves Gilbert Clinic Bowling Green Kentucky
United States Connecticut Gastroenterology Institute Bristol Connecticut
United States Commonwealth Clinical Studies PLLC Brockton Massachusetts
United States Medex Research Institute Caro Michigan
United States Dr. Deepak Sarwal, MD Centerville Ohio
United States University of North Carolina at Chapel Hill Chapel Hill North Carolina
United States Carolina Center for Liver Disease Charlotte North Carolina
United States Carolinas Medical Center Charlotte North Carolina
United States Gaffney Health Services Charlotte North Carolina
United States Charlottesville Medical Research Center Charlottesville Virginia
United States University of Virginia Charlottesville Virginia
United States ClinSearch LLC Chattanooga Tennessee
United States Gastroenterology Associates of Tidewater Chesapeake Virginia
United States Clinical Research Institute of Michigan, LLC Chesterfield Michigan
United States Metropolitan Gastroenterology Chevy Chase Maryland
United States Northwestern University-Feinberg School of Medicine Chicago Illinois
United States University of Chicago Medical Center Chicago Illinois
United States Consultants for Clinical Research Inc. Cincinnati Ohio
United States UC Health Clinical Trials Office Cincinnati Ohio
United States Cleveland Clinic Foundation Cleveland Ohio
United States University Hospitals Case Medical Center Cleveland Ohio
United States Iowa Digestive Disease Center Clive Iowa
United States University of Vermont Colchester Vermont
United States Gastro Center of Maryland Columbia Maryland
United States Columbus Regional Research Institute Columbus Georgia
United States Texas Digestive Disease Consultants Dallas Dallas Texas
United States AGA Clinical Research Associates LLC Egg Harbor Township New Jersey
United States T. Joseph Raoof MD Inc Encino California
United States Texas Digestive Disease Consultants - Southlake Flower Mound Texas
United States Sing Chan Private Practice Flushing New York
United States Florida Medical Research - Southeastern Integrated Medical Gainesville Florida
United States Sarkis Clinical Trials - Parent Gainesville Florida
United States Valley View Internal Medicine Garden Grove California
United States Gastro One Germantown Tennessee
United States NYU Langone Nassau Gastroenterology Associates Great Neck New York
United States PhysiqueMed Clinical Trials Greensboro North Carolina
United States Medical Research Center of Connecticut LLC Hamden Connecticut
United States Connecticut GI PC Research Division Hartford Connecticut
United States Main Line Gastroenterology Havertown Pennsylvania
United States NorthShore University HealthSystem Highland Park Illinois
United States Gulf Coast Research Group LLC Houston Texas
United States Houston Endoscopy and Research Center Houston Texas
United States The Methodist Hospital Research Institute Houston Texas
United States University of Texas Health Science Center at Houston Houston Texas
United States Clinical Inquest Center Ltd Huber Heights Ohio
United States ADDC Research LLC Huntsville Alabama
United States Grand Teton Research Group PLLC Idaho Falls Idaho
United States Indiana University Indianapolis Indiana
United States Borland-Groover Clinic Jacksonville Florida
United States Jefferson City Medical Group Jefferson City Missouri
United States Kinston Medical Specialists PA Kinston North Carolina
United States Innovative Clinical Research Lafayette Colorado
United States Clinical Trials of SW Louisiana LLC Lake Charles Louisiana
United States Montefiore Medical Center PRIME Lake Success New York
United States OM Research Lancaster California
United States Florida Center for Gastroenterology Largo Florida
United States Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
United States Emeritas Research Group Leesburg Virginia
United States University of Kentucky Medical Center Lexington Kentucky
United States Gastroenterology Associates PA Little Rock Arkansas
United States Cedars-Sinai Medical Center Los Angeles California
United States University of Southern California Medical Center Los Angeles California
United States University of Louisville Louisville Kentucky
United States Dean Clinic Oregon Madison Wisconsin
United States University of Wisconsin Hospital and Clinics Madison Wisconsin
United States The Feinstein Institute for Medical Research PRIME Manhasset New York
United States Arizona Digestive Health Mesa Arizona
United States Advance Medical Research Center Miami Florida
United States Cordova Research Institute Miami Florida
United States My Community Research Center inc Miami Florida
United States Sanitas Research Miami Florida
United States Galiz Research LLC Miami Springs Florida
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Winthrop University Hospital Mineola New York
United States University of Minnesota Minneapolis Minnesota
United States Facey Medical Foundation Mission Hills California
United States Clinical Trials of America, LLC Mount Airy North Carolina
United States Gastroenterology Group of Naples Naples Florida
United States Vanderbilt University Medical Center Nashville Tennessee
United States Yale University New Haven Connecticut
United States North Shore Long Island Jewish Health System New Hyde Park New York
United States Columbia University Medical Center New York New York
United States Concord Medical Group PRIME New York New York
United States Icahn School of Medicine at Mount Sinai New York New York
United States New York - Presbyterian/Weill Cornell Medical Center New York New York
United States New York University School of Medicine New York New York
United States Digestive and Liver Disease Specialists Norfolk Virginia
United States Henry Ford Medical Center - New Center One Novi Michigan
United States Oklahoma University Health Sciences Center Oklahoma City Oklahoma
United States Center For Digestive Health Orlando Florida
United States GCRM Orlando Florida
United States Drexel University College of Medicine Philadelphia Pennsylvania
United States University of Pennsylvania School of Medicine Philadelphia Pennsylvania
United States Mayo Clinic Arizona Phoenix Arizona
United States BRCR Medical Center Inc. Plantation Florida
United States Advanced Medical Research Center Port Orange Florida
United States Oregon Health and Science University Portland Oregon
United States Premier Medical Group of the Hudson Valley PC Poughkeepsie New York
United States Health Science Research Center, LLC Pratt Kansas
United States Hunter Holmes Mcguire Ctr Richmond Virginia
United States Mayo Clinic Rochester Minnesota
United States University of Rochester Rochester New York
United States East Coast Institute for Research LLC Saint Augustine Florida
United States Saint Louis University Saint Louis Missouri
United States University of Utah Salt Lake City Utah
United States Sagact Pllc San Antonio Texas
United States San Antonio Military Medical Center San Antonio Texas
United States Clinical Applications Laboratories Inc San Diego California
United States Medical Associates Research Group Inc. San Diego California
United States University of California at San Francisco San Francisco California
United States Colon & Digestive Health Specialists Scottsdale Arizona
United States Harborview Medical Center Seattle Washington
United States Swedish Medical Center Seattle Washington
United States University of Washington School of Medicine Seattle Washington
United States Virginia Mason Medical Center Seattle Washington
United States Louisiana Research Center LLC Shreveport Louisiana
United States Mercy Research Springfield Missouri
United States Springfield Health Care Center Springfield Ohio
United States Penn State University Milton S Hershey Medical Center State College Pennsylvania
United States Arizona Digestive Health Sun City Arizona
United States Atlanta Gastroenterology Specialists PC Suwanee Georgia
United States Scott & White Medical Center Temple Texas
United States Digestive Health Specialist of Tyler Tyler Texas
United States The Vancouver Clinic Vancouver Washington
United States Ventura Clinical Trials Ventura California
United States Mercy Clinic East Communities d/b/a Mercy Health Research Washington Missouri
United States Cleveland Clinic Florida Weston Weston Florida
United States Heartland Research Associates LLC Wichita Kansas
United States Via Christi Research a division of Via Christi Hospitals Wichita Inc Wichita Kansas
United States Trial Management Associates LLC Wilmington North Carolina
United States PMG Research of Winston-Salem LLC Winston-Salem North Carolina
United States Wake Forest University Baptist Medical Center Winston-Salem North Carolina
United States Shafran Gastroenterology Center Winter Park Florida
United States UMass Medical Center Worcester Massachusetts
United States Gastroenterology Associates of Western Michigan PLC Wyoming Michigan

Sponsors (1)

Lead Sponsor Collaborator
Celgene

Countries where clinical trial is conducted

United States,  Australia,  Austria,  Belgium,  Bulgaria,  Canada,  Croatia,  Czechia,  Denmark,  Estonia,  Finland,  France,  Germany,  Greece,  Hungary,  Israel,  Italy,  Korea, Republic of,  Latvia,  Malaysia,  Netherlands,  New Zealand,  Norway,  Poland,  Portugal,  Romania,  Russian Federation,  Serbia,  Slovakia,  Spain,  Sweden,  Switzerland,  Turkey,  Ukraine,  United Kingdom, 

References & Publications (1)

Gold SL, Cohen-Mekelburg S, Schneider Y, Steinlauf A. Perianal Fistulas in Patients With Crohn's Disease, Part 2: Surgical, Endoscopic, and Future Therapies. Gastroenterol Hepatol (N Y). 2018 Sep;14(9):521-528. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The Percentage of Participants Who Achieved a Clinical Remission at Week 12 Clinical remission is defined as a Crohn's Disease Activity Index (CDAI) score < 150. The Crohn's Disease Activity Index is used to quantify the signs and symptoms of Crohn's disease and the affect on patient's quality of life. It consists of 8 variables which include patient reported outcomes over a 7 day period and physician assessments which are scored numerically and weighted. Scores range from 0 to 600, with the most severe disease defined >450. Week 12
Secondary Percentage of Participants Who Achieved Clinical Remission at Week 52 Clinical remission is defined as a CDAI score < 150 and is used to quantify the signs and symptoms of Crohn's disease and the effect on patient's quality of life. It consists of 8 variables which include patient reported outcomes over a 7 day period and physician assessments which are scored numerically and weighted. Scores range from 0 to 600, with the most severe disease defined >450. Week 52
Secondary Percentage of Participants With Endoscopic Response-50 Centrally Read at Week 52 An endoscopic response-50 is defined as a reduction of at least 50% compared with baseline in simple endoscopic score for Crohn's Disease (SES-CD). The SES-CD assesses the size of mucosal ulcers, the extent of ulcerated surface, the extent of affected surface, and the presence and type of narrowings. Scores range from 0 to 60 with higher scores reflecting more severe disease. The SES-CD calculations include:
Ulcers scored as:
0: no
aphthous (0.1-0.5 cm)
large (0.5-2 cm)
very large (>2 cm)
Surface involved disease 0: 0%
<50%
50-75%
>75%
Surface involved by ulcerations:
0: 0%
<10%
10-30%
>30% - Narrowings:
0: No
Single, can be passed
Multiple, can be passed
Cannot be passed Grand Total = SES-CD score
Week 52
Secondary The Percentage of Participants Who Achieved a Clinical Response at Week 12 A clinical response is defined as a CDAI score decrease from baseline = 100 points. The CDAI is used to quantify the signs and symptoms of Crohn's disease and the effect on patient's quality of life. It consists of 8 variables which include patient reported outcomes over a 7 day period and physician assessments which are scored numerically and weighted. Scores range from 0 to 600, with the most severe disease defined >450. Week 12
Secondary The Percentage of Participants Who Achieved a Clinical Response at Week 4 A clinical response is defined as a decrease from baseline in CDAI = 100 points. The Crohn's Disease Activity Index is used to quantify the signs and symptoms of Crohn's disease and the effect on patient's quality of life. It consists of 8 variables which include patient reported outcomes over a 7 day period and physician assessments which are scored numerically and weighted. Scores range from 0 to 600, with the most severe disease defined >450. Week 4
Secondary The Percentage of Participants Who Achieved a Clinical Remission at Week 4 A clinical remission is a CDAI score < 150. The Crohn's Disease Activity Index is used to quantify the signs and symptoms of Crohn's disease and the effect on patient's quality of life. It consists of 8 variables which include patient reported outcomes over a 7 day period and physician assessments which are scored numerically and weighted. Scores range from 0 to 600, with the most severe disease defined >450. Week 4
Secondary The Percentage of Participants Who Achieved a Corticosteroid-Free Clinical Remission at Week 52 The percentage of participants who were receiving oral corticosteroids for Crohn's disease, at baseline and achieved a clinical remission (CDAI score <150) at Week 52 without corticosteroids. The Crohn's Disease Activity Index is used to quantify the signs and symptoms of Crohn's disease and the effect on patient's quality of life. It consists of 8 variables which include patient reported outcomes over a 7 day period and physician assessments which are scored numerically and weighted. Scores range from 0 to 600, with the most severe disease defined >450. Week 52
Secondary Percentage of Participants Who Achieved a Sustained Clinical Remission at Both Week 12 and 52 For participants who achieved a sustained clinical remission at both week 12 and 52, the clinical remission is a CDAI score < 150. The Crohn's Disease Activity Index is used to quantify the signs and symptoms of Crohn's disease and the effect on patient's quality of life. It consists of 8 variables which include patient reported outcomes over a 7 day period and physician assessments which are scored numerically and weighted. Scores range from 0 to 600, with the most severe disease defined >450. Weeks 12 and 52
Secondary Percentage of Participants With Endoscopic Response-25 Centrally Read at Week 12 An endoscopic response-25 is defined as a reduction of at least 25% compared with baseline in simple endoscopic score for Crohn's disease (SES-CD). The SES-CD assesses the size of mucosal ulcers, the extent of ulcerated surface, the extent of affected surface, and the presence and type of narrowings. Scores range from 0 to 60 with higher scores reflecting more severe disease. The SES-CD calculations include:
Ulcers scored as:
0: no
aphthous (0.1-0.5 cm)
large (0.5-2 cm)
very large (>2 cm)
Surface involved disease 0: 0%
<50%
50-75%
>75%
Surface involved by ulcerations:
0: 0%
<10%
10-30%
>30% - Narrowings:
0: No
Single, can be passed
Multiple, can be passed
Cannot be passed Grand Total = SES-CD score
Week 0, Week 12
Secondary Percentage of Participants With Endoscopic Remission Centrally Read at Week 52 Endoscopic remission is defined as a simple endoscopic score for Crohn's disease (SES-CD) of =2 at the specified timeframe. The SES-CD assesses the size of mucosal ulcers, the extent of ulcerated surface, the extent of affected surface, and the presence and type of narrowings. Scores range from 0 to 60 with higher scores reflecting more severe disease. The SES-CD calculations include:
Ulcers scored as:
0: no
aphthous (0.1-0.5 cm)
large (0.5-2 cm)
very large (>2 cm)
Surface involved disease 0: 0%
<50%
50-75%
>75%
Surface involved by ulcerations:
0: 0%
<10%
10-30%
>30% - Narrowings:
0: No
Single, can be passed
Multiple, can be passed
Cannot be passed Grand Total = SES-CD score
Week 52
Secondary The Number of Participants Who Experienced Treatment Emergent Adverse Events (TEAE) From Week 0 to Week 52 A TEAE was defined as any adverse event (AE) occurring or worsening on or after the first treatment of GED-0301 and up to 28 days after the last GED-0301 dose or the last follow-up date, whichever occurred earlier. A serious AE = any AE which results in death; is life-threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; constitutes an important medical event. From the first day of GED-0301 until 28 days after the last dose of investigational product (IP); maximum treatment duration was 52.6 weeks
Secondary The Number of Participants Who Discontinued IP Due to an Treatment Emergent Adverse Events A TEAE was defined as any AE occurring or worsening on or after the first dose of GED-0301 and up to 28 days after the last GED-0301 dose or the last follow-up date, whichever occurred earlier. A serious AE = any AE which results in death; is life-threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; constitutes an important medical event. The severity of AEs was assessed by the investigator and based on the following scale: Mild = asymptomatic or mild symptoms; clinical or diagnostic observations only; Moderate = Symptoms cause moderate discomfort; Severe (could be non-serious or serious) = symptoms causing severe discomfort/pain. From the first day of GED-0301 until 28 days after the last dose of IP; maximum treatment duration was 52.6 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04046913 - The ADDapt Diet in Reducing Crohn's Disease Inflammation N/A
Recruiting NCT05169593 - Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy Phase 4
Recruiting NCT06116604 - Early Bowel Resection for Terminal Ileal Crohn's Disease
Recruiting NCT05627128 - A Culturally Tailored Dietary Intervention to Treat Crohn's Disease N/A
Recruiting NCT05294107 - Intestinal Organoids N/A
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Withdrawn NCT04349449 - ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Completed NCT03058679 - Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease N/A
Completed NCT02871635 - BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity Phase 3
Recruiting NCT04539665 - Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease. N/A
Recruiting NCT04266600 - Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease N/A
Recruiting NCT03913572 - Treatment of Perianal Disease Using Adipose-derived Stem Cells
Completed NCT03668249 - A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
Completed NCT03606499 - Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
Terminated NCT04102111 - A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease Phase 2
Recruiting NCT04997733 - Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal Phase 3
Recruiting NCT05906576 - Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients Phase 4
Not yet recruiting NCT04502303 - 18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease Phase 2
Not yet recruiting NCT04398836 - Preoperative Nutrition for Crohn's Disease Patients Phase 3